Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
8.07
-0.69 (-7.88%)
At close: Oct 31, 2025, 4:00 PM EDT
7.84
-0.23 (-2.85%)
After-hours: Oct 31, 2025, 7:32 PM EDT
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $559.3 million as of October 31, 2025. Its market cap has decreased by -70.53% in one year.
Market Cap
559.30M
Enterprise Value
-154.95M
1-Year Change
-70.53%
Ranking
Category
Stock Price
$8.07
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $559.30M, an increase of 163.38%. That is a compound annual growth rate of 16.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 559.30M | -42.14% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | 382.42M | 126.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |